Positive and Negative Air Pressure Target Position Therapy Apparatus
Positive and Negative Air Pressure Target Position Therapy Apparatus
Positive and Negative Air Pressure Target Position Therapy Apparatus
Positive and Negative Air Pressure Target Position Therapy Apparatus
Positive and Negative Air Pressure Target Position Therapy Apparatus
"Jianyouxiang" positive and negative air pressure target therapy instrument is to establish a positive pressure sealed high-temperature drug delivery environment on the surface of acupoints,open up the drug channel of the skin stratum corneum through negative pressure adsorption, break through the capillary network and use the meridian to achieve high-efficiency linear drug delivery.
  • Positive pressure 0.5kpa ~ 5kpa
  • Power SupplyAC220V;50Hz/60Hz
  • Outline dimensions of main engine500 mm×530 mm×950mm
  • Negative pressureWhen the negative pressure reaches (-50kPa) ± 5kPa within 45min, the control system will automatically shut down; the minimum value reaches (-30kPa)±5kPa, the control systemwill automatically start
  • Product Details

IAbout the products

 

      "Jianyouxiang" positive and negative air pressure target therapy instrument is to establish a positive pressure sealed high-temperature drug delivery environment on the surface of acupoints, open up the drug channel of the skin stratum corneum through negative pressure adsorption, break through the capillary network and use the meridian to achieve high-efficiency linear drug delivery. The standardized targeted therapy of traditional Chinese medicine has increased the efficiency of drug absorption by hundreds of times.

 

 

IIUnique treatment plan

 

 

             

 

 

IIIPrinciple of administration

 

      Establish a continuous drug delivery channel through pressure to allow drug molecules to break through the stratum corneum to reach the skin tissues of the acupoints.

     

      Through negative pressure adsorption, the "diseased tissue area" and the "drug molecule storage area" form a flowing meridian channel through which drug molecules reach the interstitial fluid space of the diseased area under the action of the meridian effect.

 

 

 

 

IV Principle of administration

 

      Establish a positive pressure sealed high-temperature drug delivery environment in the acupoint area, and then break through the skin stratum corneum to open a continuous drug delivery channel under the action of negative pressure adsorption, so that drug molecules enter the interstitial fluid space of the diseased tissue through the meridian channel, forming a high-concentration drug infiltration area , Enable the effective absorption of drug molecules at the site of the case to achieve the purpose of targeted drug delivery.

 

                 

 

 

VPain points resolved

 

      The efficiency of Chinese medicine administration is low, and it is difficult to form an effective therapeutic concentration of the drug at the site to be treated The amount of traditional Chinese medicine used is large, and the patient’s liver and kidney functions are burdened The loss and escape of active ingredients in the process of Chinese medicine administration greatly reduces the synergistic effect of Chinese medicine prescriptions The treatment prescription is difficult to replicate.

 

 

VICore technologies

 

 

1,Precise algorithm to open the meridian channel for continuous drug delivery

2,High air pressure is not traumatic

3,High temperature does not burn

4,Confidential standard prescription of traditional Chinese Medicine

5,Improve drug absorption efficiency

a,Sealed high temperature drug delivery environment

b,Positive pressure thrust negative pressure adsorption

c,Precision algorithm control channel

 

 

VIIAdapt to the disease

 

 

      1, Respiratory diseases: chronic obstructive pulmonary disease, new coronary pneumonia, asthma, alveolar proteinosis, cough after a cold, bronchiectasis, etc

      2, Pediatrics: Pediatric respiratory system common diseases such as pediatric cough, pediatric bronchitis, and pediatric pneumonia

      3, Andrology: Chronic prostatitis

 

 

VIIIPreliminary effect of pre-clinical application

 

Diseases

 

Number of cases

 

 

Number of

 

treatments

 

 

The number of each

 

group

Upturn

Not cured

Efficiency

 Cold and cough

100

1-5

30

21

9

70.00%

6-10

20

17

3

85.00%

11-15

20

16

4

80.00%

16-20

20

18

2

90.00%

21-25

10

8

2

80.00%

 

 

COPD

 25

1-5

7

4

3

57.14%

6-10

5

3

2

60.00%

11-15

5

4

1

80%

16-20

3

2

1

66.7%

21-25

5

4

1

80.00%

 

 

  Bronchial asthma

 

64

1-5

30

15

15

50.00%

6-10

13

9

4

69.23%

11-15

14

11

3

78.57%

16-20

7

6

1

85.71%

 

IXPreliminary effect of pre-clinical application

 

pplicable diseases

 

Course of treatment

 

 (24 days/course).

Efficacy description

Chronic bronchitis

1-3courses

It has been clinically proven to effectively alleviate clinical symptoms such as cough, sputum,

 

wheezing or shortness of breath, and promote the improvement of the quality of life.

Prostatitis

7-20days

After 10 days of treatment, there is no nocturia or occasionally after going to bed at night

 

, which can relieve or clinically cure the symptoms of lower abdominal pain, swelling, frequent

 

urination, urgency, burning urethra.

 

 

Cold and cough

 

2-3days

Clinically cured cough or cough and asthma for about 3 times .

COPD

 

3-4courses

By clinical validation, mild illness can be blocked or reversed, severe illness can reduce

the frequency of acute attacks, improve short of breath and other symptoms .

Asthma

 

2-3courses

 

Clinically verified, children under 12 years old and mild patients can be cured clinically,

and severe patients can relieve or eliminate cough and asthma symptoms.